ATE286728T1 - Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen - Google Patents

Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen

Info

Publication number
ATE286728T1
ATE286728T1 AT99110376T AT99110376T ATE286728T1 AT E286728 T1 ATE286728 T1 AT E286728T1 AT 99110376 T AT99110376 T AT 99110376T AT 99110376 T AT99110376 T AT 99110376T AT E286728 T1 ATE286728 T1 AT E286728T1
Authority
AT
Austria
Prior art keywords
bacterial infections
homocysteine
treat bacterial
derivatives
homocysteine derivatives
Prior art date
Application number
AT99110376T
Other languages
English (en)
Inventor
Massimo Nicola
Marco Inglesi
Original Assignee
Edmond Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edmond Pharma Srl filed Critical Edmond Pharma Srl
Application granted granted Critical
Publication of ATE286728T1 publication Critical patent/ATE286728T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99110376T 1998-06-05 1999-05-28 Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen ATE286728T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001267A ITMI981267A1 (it) 1998-06-05 1998-06-05 Uso di derivati dell'omocisteina per la preparazione di farmaci destinati ad inibire l'adesivita'batterica

Publications (1)

Publication Number Publication Date
ATE286728T1 true ATE286728T1 (de) 2005-01-15

Family

ID=11380184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99110376T ATE286728T1 (de) 1998-06-05 1999-05-28 Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen

Country Status (8)

Country Link
EP (1) EP0974353B1 (de)
KR (1) KR100676850B1 (de)
AT (1) ATE286728T1 (de)
DE (2) DE974353T1 (de)
DK (1) DK0974353T3 (de)
ES (1) ES2236989T3 (de)
HK (1) HK1022420A1 (de)
IT (1) ITMI981267A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000016816A1 (it) * 2020-07-10 2022-01-10 Edmond Pharma Srl Composizioni comprendenti composti antiossidanti come coadiuvanti nel trattamento di infezioni virali
EP4316481A1 (de) 2022-08-01 2024-02-07 Edmond Pharma S.R.L. Erdostein, salze, enantiomere oder metabolite davon zur verwendung bei der behandlung von akuten und chronischen schmerzzuständen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173441B (it) * 1984-03-14 1987-06-24 Edmond Pharma Srl Sali di eritromicina con derivati dell'acido acetico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
ES2236989T3 (es) 2005-07-16
KR20000005879A (ko) 2000-01-25
ITMI981267A1 (it) 1999-12-05
DE974353T1 (de) 2000-08-17
EP0974353A3 (de) 2000-03-08
DE69923117D1 (de) 2005-02-17
EP0974353A2 (de) 2000-01-26
KR100676850B1 (ko) 2007-01-31
HK1022420A1 (en) 2000-08-11
DK0974353T3 (da) 2005-05-23
EP0974353B1 (de) 2005-01-12
DE69923117T2 (de) 2005-12-29

Similar Documents

Publication Publication Date Title
ATE248837T1 (de) Chinuclidin-acrylamide
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MX9707453A (es) Derivados de quinazolina.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
BR0109703A (pt) Derivados de piperazina
NO996108L (no) 9-oksinerytromycinderivater
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
SE9504661D0 (sv) New compounds
SE9604786D0 (sv) New compounds
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
AP9701041A0 (en) Pyridylpyrrole compounds.
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
SE9802208D0 (sv) Novel compounds
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
PT992509E (pt) Novos derivados macrolidos
DK1057828T3 (da) Orale trovafloxacin-suspensioner
ATE289204T1 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
SE9802209D0 (sv) Novel compounds
BR0009101A (pt) 9a-azalidas com atividade antibacteriana
NO982863L (no) Nye forbindelser med analgetisk effekt
ATE328898T1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
SE0102058D0 (sv) New Salts II
SE9802538D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties